Jump to content


Lauren Taggart

Member Since 18 Apr 2016
Offline Last Active May 26 2017 10:42 AM
-----

Topics I've Started

In-Memoriam: Adele Boskey, Ph.D.

04 May 2017 - 09:16 AM

It is with great sadness that we announce the passing of long-time member Adele Boskey, Ph.D., a senior scientist at Hospital for Special Surgery (HSS).

Dr. Boskey was a pioneer in the bone mineralization field. Among her many discoveries and contributions to the field, Dr. Boskey was a pioneer in characterizing bone mineral changes in skeletal diseases such as osteoporosis and rickets. She was the 2015 recipient of the ASBMR Lawrence G. Raisz Esteemed Award for outstanding achievements in preclinical translational research in the bone and mineral field. Her recent work suggests that measuring bone quality, rather than bone density, promises greater accuracy and could predict what characteristics of bone put patients at risk of fracture.

A lifelong volunteer and mentor, Dr. Boskey served many years on various committees and boards in ASBMR, ORS, IADR, NOF, AAOS, and OIF. A recognized mentor of countless grad students, postdocs, and early career scientists, Dr. Boskey was known for generously giving her time and expertise to all who asked.

In celebration of the life of Dr. Adele Boskey, please join colleagues at Hospital for Special Surgery for a memorial service honoring her on Wednesday May 17 at 6 -8 PM. The celebration will be held in the Richard L. Menschel Education Center located at Hospital for Special Surgery, 535 East 70th Street, 2nd Floor.

You can also join us in recognizing Dr. Boskey’s contribution to our field by leaving a note below, sharing a memory, or contributing a donation in her honor.

In Memoriam: Robert Heaney, M.D.

10 August 2016 - 01:07 PM

It is with sadness that we announce the passing of Robert P. Heaney, M.D., one of the giants in our field.

Dr. Heaney was born in Omaha and spent most of his life in his hometown and at his alma mater, Creighton University. He received his bachelor’s degree from Creighton University and his medical degree from Creighton’s School of Medicine in 1951. He became a faculty member at Creighton in 1957, and served as the university’s first vice president for health sciences. He was also the first to hold the John A. Creighton University Professorship.

A recipient of the ASBMR Frederic C. Bartter Award in 1994, Dr. Heaney was a pioneering researcher whose decades of research elevated the national conversation about osteoporosis and the importance of calcium and vitamin D to bone health. Recognized by the National Osteoporosis Foundation as a “Legend of Osteoporosis,” Dr. Heaney worked with the Institute of Medicine to determine a recommended daily dose of calcium. Over the course of his professional career, he wrote 866 papers, scientific articles, reviews, editorials and other manuscripts, as well as three books.

In addition to his many contributions to the field of bone science and nutrition, Dr. Heaney will be remembered as a healer, a thinker and a man of grace and generosity. Please join us in recognizing Dr. Heaney’s contributions to our field by leaving a note, sharing a memory or contributing a donation in his honor to the ASBMR Fund for Research and Education.

In Memoriam: Dr. Marion "Dave" David Francis

27 July 2016 - 10:58 AM

We are sad to announce that ASBMR member Dr. Marion David Francis passed away on May 10, 2016, a day after his 93rd birthday.

Dr. Francis was born in Vancouver, Canada and gained his BSc and MSc degrees in physics and chemistry at the University of British Columbia, followed by a PhD at the University of Iowa. In 1952, he joined the Procter and Gamble Company (P&G) in Cincinnati, Ohio, USA where he spent the rest of his professional career, publishing over 100 papers and 35 patents. He remained actively engaged in laboratory science until his retirement in 1993.

He made major scientific discoveries in the dental and medical fields that have endured to the present day. His basic research on the chemistry of tooth enamel and dentine helped to lay the scientific foundation for the effective use of fluoride to prevent cavities. Fluoride-containing toothpastes continue to be used more than 50 years later.

The extension of his work to controlling the formation of hydroxyapatite, with a view to preventing dental calculus and plaque, led to an interest in phosphonates as stable chemical analogues to influence these processes, as had previously been shown for pyrophosphate.

This work led to the collaboration with Herbert Fleisch and Graham Russell that resulted in the first recognition of the important biological effects of the chemically stable bisphosphonates (then called diphosphonates) in the prevention of calcification and especially bone resorption. Dr. Francis played an important role in enabling the early clinical use of bisphosphonates, and derived great pleasure from their success.

Dr. Francis’s third long-lasting contribution to medicine was to pioneer the development of radiolabeled bisphosphonates to detect abnormal metabolic bone activity. The use of 99mTc-labelled bisphosphonates was first commercialized at P&G and these imaging agents continue to be used today.

His inventions improved the lives of millions of people around the world. For these significant achievements, Dr. Francis received several honors, including the Perkin Medal and "Hero of Chemistry" award from the American Chemical Society, and election to the prestigious Victor Mills Society at P&G.

Please join us in recognizing Dr. Francis’s contribution to our field by leaving a note, sharing a memory, or contributing a donation in his honor.

In Memoriam: Ignac Fogelman, M.D.

07 July 2016 - 08:48 AM

We are sad to announce that Professor Ignac Fogleman passed away on July 5th following a long and courageous fight against cancer. He received his medical degree at Glasgow University and took up the post of Consultant Physician at Guy’s and St. Thomas’ Hospital, London UK in 1983. He served as director of the Department of Nuclear Medicine between 1988-97 and became Director of the Osteoporosis Screening and Research Unit in 1988. During his time in Glasgow, under the supervision of Dr Iain Boyle, Ignac developed the technique of bone scanning using technetium-99m labelled diphosphonate compounds, which was widely used in the investigation of many metabolic bone disorders including osteomalacia, bone malignancy and Paget’s disease. In later years his research group at Guy’s and St Thomas’ Hospitals were leaders in the development of (18)F-fluoride positron emission tomography for the study of regional changes in bone remodeling in untreated and treated bone disease. He was closely involved with the National Osteoporosis Society for many years, serving as a Board Member between 1997 and 1998 and Chairman of its Densitometry Forum between 1999 and 2005.

In addition to his many contributions to the bone field, Ignac will be remembered as a man of culture, wit and humanity. He will be greatly missed by his many friends and colleagues.